Generix SA

ENXTPA:GENX Stock Report

Market Cap: €220.0m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Generix Balance Sheet Health

Financial Health criteria checks 5/6

Key information

31.96%

Debt to equity ratio

€15.09m

Debt

Interest coverage ratio12.8x
Cash€15.52m
Equity€47.20m
Total liabilities€72.87m
Total assets€120.07m

Recent financial health updates

Recent updates

Analysis Article Apr 29

Returns On Capital Are Showing Encouraging Signs At Generix (EPA:GENX)

What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Analysis Article Mar 30

A Look At The Fair Value Of Generix SA (EPA:GENX)

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Generix SA ( EPA:GENX...
Analysis Article May 04

Generix (EPA:GENX) Has More To Do To Multiply In Value Going Forward

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...
Analysis Article Mar 08

What Kind Of Investors Own Most Of Generix SA (EPA:GENX)?

Every investor in Generix SA ( EPA:GENX ) should be aware of the most powerful shareholder groups. Institutions will...
Analysis Article Feb 15

Is Generix's (EPA:GENX) 194% Share Price Increase Well Justified?

When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really...
Analysis Article Jan 27

Does Generix (EPA:GENX) Have A Healthy Balance Sheet?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article Jan 09

Here's What To Make Of Generix's (EPA:GENX) Returns On Capital

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analysis Article Dec 22

Does Generix's (EPA:GENX) Statutory Profit Adequately Reflect Its Underlying Profit?

Many investors consider it preferable to invest in profitable companies over unprofitable ones, because profitability...
Analysis Article Dec 07

Could The Market Be Wrong About Generix SA (EPA:GENX) Given Its Attractive Financial Prospects?

With its stock down 6.6% over the past three months, it is easy to disregard Generix (EPA:GENX). But if you pay close...
Analysis Article Nov 19

What Is Generix SA's (EPA:GENX) Share Price Doing?

Generix SA (EPA:GENX), is not the largest company out there, but it saw significant share price movement during recent...

Financial Position Analysis

Short Term Liabilities: GENX's short term assets (€56.6M) do not cover its short term liabilities (€57.6M).

Long Term Liabilities: GENX's short term assets (€56.6M) exceed its long term liabilities (€15.3M).


Debt to Equity History and Analysis

Debt Level: GENX has more cash than its total debt.

Reducing Debt: GENX's debt to equity ratio has reduced from 33.6% to 32% over the past 5 years.

Debt Coverage: GENX's debt is well covered by operating cash flow (82.6%).

Interest Coverage: GENX's interest payments on its debt are well covered by EBIT (12.8x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/09/13 11:51
End of Day Share Price 2022/08/23 00:00
Earnings2022/03/31
Annual Earnings2022/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Generix SA is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jean Pascal BrivadyCIC Market Solutions (ESN)
Emmanuel MatotODDO BHF Corporate & Markets
Matthias DesmaraisODDO BHF Corporate & Markets